This article has been cited by
1Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study
Maria Duarte,Paula Ferreira,Maria Soares,Afonso Cavaco,Ana Paula Martins
Drugs & Therapy Perspectives.2015;31(9)316
[DOI]
2Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 – 2012
Carmen Ferrajolo,Annalisa Capuano,Gianluca Trifirò,Ugo Moretti,Francesco Rossi,Carmela Santuccio
Expert Opinion on Drug Safety.2014;13(sup1)9
[DOI]
3Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 – 2012
Reem K. Al-Essa,Mohammed Al-Rubaie,Stuart Walker,Sam Salek
Expert Opinion on Drug Safety.2015;13(sup1)115
[DOI]
4Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation
Christian Leporini,Giuseppina Marrazzo,Laura Mumoli,Stefania Esposito,Luca Gallelli,Giovanna Mangano,Giacomino Brancati,Emanuela Adele De Francesco,Emilio Russo,Giovambattista De Sarro
Expert Opinion on Drug Safety.2017;16(5)515
[DOI]
5Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
Abimbola O. Opadeyi,Annie Fourrier-Réglat,Ambrose O. Isah
BMC Pharmacology and Toxicology.2018;19(1)515
[DOI]
  Feedback 
  Subscribe